The Society of Gynecologic Oncologists (SGO) held its “Women’s Cancer” annual meeting on March 9-12th in Tampa, Florida. I have provided below links to several DG Dispatch and medpage Today news releases that summarize important SGO meeting abstracts and presentations:

• A Phase 2 Trial of SNS-595 in Women With Platinum Resistant Epithelial Ovarian Cancer. [Source: 2008 SGO Annual Mtg. Abstract #290].

• A Randomized Phase II Study of Standard-Versus High-Dose Pemetrexed in Platinum-Resistant Epithelial Ovarian Cancer. [Source: 2008 SGO Annual Mtg. Abstract #256].

• Diagnostic and Prognostic Significance of Neutrophil to Lymphocyte Ratio Along With CA125 in Ovarian Cancer. [Source: 2008 SGO Annual Mtg. Abstract #70].

• Surgical Cytoreduction and Dose Intensity of Adjuvant Paclitaxel and Carboplatin Chemotherapy in Advanced Epithelial Ovarian Cancer. [Source: 2008 SGO Annual Mtg. Abstract #125].

• Recurrent Low-Grade Carcinoma of the Ovary Is Less Responsive to Chemotherapy Than More Common Ovarian Cancers. [Source: Retrospective Study by David M. Gershenson, MD, Professor and Chair of the Department of Gynecologic Oncology, M.D. Anderson Cancer Center, Houston, Texas at the 2008 SGO Annual Mtg.]

• Decrease in Perioperative Venous Thromboembolism With Use of Dual Prophylaxis in Patients With Gynecologic Cancer. [Source: 2008 SGO Annual Mtg. Abstract #42].

• Impact of Statin Therapy on Outcome in Epithelial Ovarian Cancer. [Source: 2008 SGO Annual Meeting Abstract #39].

• Peak postoperative glucose levels predict complications after primary cytoreductive surgery for advanced ovarian cancer; Retrospective Chart Review; Allison E. Axtell, M.D., Olive View Medical Center in Los Angeles. [Source: 2008 SGO Annual Mtg. Abstract #97.]

• “The potential benefit of six versus three cycles of chemotherapy in subsets of women with high-risk early-stage epithelial ovarian cancer: An exploratory analysis of a Gynecologic Oncology Group study.” [Source: 2008 SGO Annual Mtg. Abstract #4].

• “Quality of prophylactic, perioperative antibiotic prophylaxis in gynecologic surgery: Too much of a good thing?” [Source: 2008 SGO Annual Mtg. Abstract #341].